Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer
Clinical trial NCT01724866 · COMPLETED
Trial details
- NCT number
- NCT01724866
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-25
- Primary completion
- 2014-08-12
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.